ArticleAnnals of translational medicine2021

Phosphoproteomics identifies potential downstream targets of the integrin α2β1 inhibitor BTT-3033 in prostate stromal cells.

Bingsheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.